Cancer Network posts 12-episode series titled “The Future of Decision-Making in Colorectal Cancer: ctDNA’s Emerging Role” in which expert panelists discuss management of colorectal cancer using minimal residual disease (MRD) and circulating tumor DNA (ctDNA) testing and clinical trial outcomes.
![ctDNA emerging role](https://i0.wp.com/crcmrd.com/wp-content/uploads/2024/04/ctDNA-emerging-role.jpg?fit=1626%2C699&ssl=1)